<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01413841</url>
  </required_header>
  <id_info>
    <org_study_id>DELUCA2</org_study_id>
    <nct_id>NCT01413841</nct_id>
  </id_info>
  <brief_title>Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief</brief_title>
  <acronym>OXYPAIN</acronym>
  <official_title>Phase II Randomised Study of Nasal Oxygen Treatment for Pain Relief During Percutaneous Coronary Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nasal oxygen is widely used as pain relief against ischemic pain during Percutaneous Coronary
      Intervention (PCI). However, to our knowledge no randomised clinical trials have tested this.
      In contrast, oxygen causes coronary artery vasoconstriction in man. Furthermore, a recent
      Cochrane meta-analysis has shown no evidence of beneficial effect of oxygen for patients with
      acute myocardial infarction (with normal blood saturation. The investigators therefore wanted
      to examine if oxygen reduces ischemic pain during PCI for stable angina or NSTEMI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Chest pain measured with VAS</measure>
    <time_frame>1 h</time_frame>
    <description>After PCI patient is asked in a double blinded about maximum chest during PCI.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Troponin-levels after PCI</measure>
    <time_frame>2 days</time_frame>
    <description>Peak troponin the first days after PCI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Angina</condition>
  <arm_group>
    <arm_group_label>Nasal oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 liter per minute</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal Air</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>3 l regular nasal air</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nasal oxygen</intervention_name>
    <description>3 l oxygen</description>
    <arm_group_label>Nasal oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Regular nasal air</intervention_name>
    <description>3 l nasal air</description>
    <arm_group_label>Nasal Air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable angina or NST-ACS undergoing PCI

        Exclusion Criteria:

          -  Blood oxygen &lt;95%

          -  Cognitive dysfunction

          -  STEMI

          -  Intubation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Skane University Hospital, Lund</name>
      <address>
        <city>Lund</city>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2011</study_first_submitted>
  <study_first_submitted_qc>August 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2011</study_first_posted>
  <last_update_submitted>August 9, 2012</last_update_submitted>
  <last_update_submitted_qc>August 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PCI</keyword>
  <keyword>oxygen</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

